C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61K 31/505 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01) C07D 487/04 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2695251
Compounds of Formula (I), a tautomer or stereoisomer thereof, or a salt thereof,wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibi tors of the Pi3K/Akt pathway.
Des composés de Formule (I), sur un tautomère ou un stéréoisomère de ceux-ci ou sur un sel de ceux-ci, où le noyau B et l'imidazole auquel il est fusionné, R4, R6 et R7 ont les significations telles que données dans la description et les revendications, sont des inhibiteurs efficaces de la voie Pi3K/Akt.
Baer Thomas
Beckers Thomas
Bhise Umesh
Chavan Sunil
Gekeler Volker
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Fused imidazoles for cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused imidazoles for cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused imidazoles for cancer treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2079524